Name
des95uc
Label
SpO2 Range/Position: 95-97% Cumulative Upright
Units
minutes
Type
numeric
Visit number vs SpO2 Range/Position: 95-97% Cumulative Upright
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 316 | 2.6 | ± 6.4 | 0.7 | 0.0 | 54.5 | 2 | 318 |
Follow-up | 275 | 5.4 | ± 15.8 | 1.3 | 0.0 | 155.9 | 26 | 301 |
Treatment Arm vs SpO2 Range/Position: 95-97% Cumulative Upright
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 2.6 | ± 6.4 | 0.7 | 0.0 | 54.5 | 2 | 318 |
HLSE | 106 | 2.8 | ± 6.4 | 0.6 | 0.0 | 38.6 | - | 106 |
HLSE-O | 105 | 2.7 | ± 6.3 | 0.8 | 0.0 | 48.0 | 1 | 106 |
HLSE-P | 105 | 2.4 | ± 6.6 | 0.7 | 0.0 | 54.5 | 1 | 106 |
Treatment Arm vs SpO2 Range/Position: 95-97% Cumulative Upright
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 5.4 | ± 15.8 | 1.3 | 0.0 | 155.9 | 26 | 301 |
HLSE | 94 | 6.4 | ± 18.5 | 1.5 | 0.0 | 155.9 | 6 | 100 |
HLSE-O | 95 | 4.7 | ± 13.6 | 1.4 | 0.0 | 105.1 | 6 | 101 |
HLSE-P | 86 | 4.9 | ± 15.1 | 0.8 | 0.0 | 116.2 | 14 | 100 |
Age category vs SpO2 Range/Position: 95-97% Cumulative Upright
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 2.6 | ± 6.4 | 0.7 | 0.0 | 54.5 | 2 | 318 |
45-54 years | 52 | 1.4 | ± 4.2 | 0.3 | 0.0 | 29.4 | 1 | 53 |
55-64 years | 139 | 2.1 | ± 4.7 | 0.8 | 0.0 | 37.4 | - | 139 |
65 years or older | 125 | 3.7 | ± 8.3 | 1.0 | 0.0 | 54.5 | 1 | 126 |
Age category vs SpO2 Range/Position: 95-97% Cumulative Upright
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 5.4 | ± 15.8 | 1.3 | 0.0 | 155.9 | 25 | 300 |
45-54 years | 42 | 5.7 | ± 12.6 | 1.2 | 0.0 | 69.1 | 7 | 49 |
55-64 years | 117 | 4.9 | ± 15.3 | 1.0 | 0.0 | 116.2 | 10 | 127 |
65 years or older | 116 | 5.7 | ± 17.4 | 1.6 | 0.0 | 155.9 | 8 | 124 |
Gender vs SpO2 Range/Position: 95-97% Cumulative Upright
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 2.6 | ± 6.4 | 0.7 | 0.0 | 54.5 | 2 | 318 |
Female | 84 | 3.3 | ± 8.8 | 0.6 | 0.0 | 54.5 | - | 84 |
Male | 232 | 2.4 | ± 5.2 | 0.7 | 0.0 | 48.0 | 2 | 234 |
Gender vs SpO2 Range/Position: 95-97% Cumulative Upright
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 5.4 | ± 15.8 | 1.3 | 0.0 | 155.9 | 26 | 301 |
Female | 73 | 7.3 | ± 23.7 | 1.0 | 0.0 | 155.9 | 6 | 79 |
Male | 202 | 4.7 | ± 11.7 | 1.3 | 0.0 | 105.1 | 20 | 222 |
Race vs SpO2 Range/Position: 95-97% Cumulative Upright
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 311 | 2.7 | ± 6.4 | 0.7 | 0.0 | 54.5 | 2 | 313 |
White | 251 | 2.4 | ± 6.0 | 0.7 | 0.0 | 54.5 | 1 | 252 |
Black | 41 | 4.6 | ± 9.3 | 0.9 | 0.0 | 37.4 | 1 | 42 |
Other | 19 | 1.3 | ± 2.3 | 0.4 | 0.0 | 8.3 | - | 19 |
Race vs SpO2 Range/Position: 95-97% Cumulative Upright
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 271 | 5.4 | ± 15.9 | 1.3 | 0.0 | 155.9 | 25 | 296 |
White | 219 | 5.4 | ± 16.9 | 1.1 | 0.0 | 155.9 | 18 | 237 |
Black | 34 | 3.1 | ± 4.4 | 1.4 | 0.0 | 17.2 | 6 | 40 |
Other | 18 | 9.0 | ± 17.4 | 2.0 | 0.0 | 69.1 | 1 | 19 |